Immunovant, Inc. Share Price
NASDAQ: IMVT | Mid CapImmunovant, Inc. Stock Performance
Immunovant, Inc. Share Price Today
As of 8 October 2026, Immunovant, Inc.'s share price is $32.04. The stock opened at $31.82, compared to its previous close of $32.10. During today's trading session, Immunovant, Inc.'s share price traded between $31.82 and $32.68, with an average price of $32.25. Over the past 52 weeks, the stock has recorded a high of $45.26 and a low of $15.96. In terms of performance, Immunovant, Inc.'s share price has risen by 18.01% over the last six months and is up 29.80% on a year-on-year basis.
Immunovant, Inc. Share Price Chart
Immunovant, Inc. Quarterly Profit & Loss
All figures in USD
Immunovant, Inc. Annual Profit & Loss
All figures in USD
About Immunovant, Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Immunovant, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $34.09 | $31.99 | -5.36% |
Sep 2026 | $40.52 | $33.80 | -22.86% |
Aug 2026 | $38.32 | $43.81 | +13.39% |
Jul 2026 | $38.55 | $38.64 | +0.23% |
Jun 2026 | $32.75 | $38.55 | +15.87% |
May 2026 | $27.41 | $33.27 | +22.54% |
Apr 2026 | $25.04 | $27.15 | +9.21% |
Mar 2026 | $27.11 | $24.86 | -10.41% |
Feb 2026 | $25.80 | $27.75 | +6.63% |
Jan 2026 | $25.68 | $26.02 | +2.42% |
Dec 2025 | $23.86 | $25.41 | +5.13% |
Nov 2025 | $24.64 | $24.17 | -2.09% |